Selected by Scripps Research, Fitbit is first wearable brand in
historic precision medicine study
SAN FRANCISCO--(BUSINESS WIRE)--
Fitbit
(NYSE:FIT), the leading global wearables brand, and the National
Institutes of Health (NIH) today launched the Fitbit
Bring-Your-Own-Device (BYOD) project, the first digital health
technology initiative for the All of Us Research Program. Fitbit
users currently enrolled in the program can now choose to sync their
Fitbit accounts to help researchers unlock deeper insights into the
relationships between health indicators such as physical activity, heart
rate, sleep and health outcomes. By consenting to sync their data with All
of Us, Fitbit users have the opportunity to contribute to one of the
world’s largest precision medicine studies and help build one of the
most diverse data sets for scientific research. Fitbit is the first
wearable to be included in the program.
Launched nationally in May 2018, All of Us seeks to enroll one
million or more participants, with the goal of improving the
ability to prevent and treat disease based on individual differences in
lifestyle, environment and genetics. Participants will be invited to
share different types of health information over time through surveys,
electronic health records, physical measurements, biosamples and digital
health technologies. Data will be made accessible to researchers for a
wide range of health studies, with strict safeguards in place to protect
participant privacy.
“Collecting real-world, real-time data through digital technologies will
become a fundamental part of the program,” said Eric Dishman, director
of the All of Us Research Program. “This information in
combination with many other data types will give us an unprecedented
ability to better understand the impact of lifestyle and environment on
health outcomes and, ultimately, develop better strategies for keeping
people healthy in a very precise, individualized way.”
As a national leader in research using digital health technologies,
Scripps Research is spearheading the program’s digital health effort. In
2017, Scripps Research selected Fitbit as the first wearable for use in
the groundbreaking All of Us program, based on the popularity and
credibility of its use in peer-validated clinical research. An analysis1 published
by the Federation of American Societies for Experimental Biology (FASEB)
Journal found that Fitbit devices are the most commonly used tracker in
biomedical research. To date, more than 6752 published
studies have used a Fitbit device and according to a recent analysis,
Fitbit is registered in ClinicalTrials.gov studies 10 times as often
than other brands.3 This includes the use of Fitbit devices
in areas such as diabetes, cardiovascular health, oncology, mental
health and post-surgery.
“This is a tremendous opportunity for Fitbit users who choose to
participate, to further contribute to one of the world’s largest
research efforts by providing information that can help pave the way to
a healthier future for all of us,” said Adam Pellegrini, general
manager, Fitbit Health Solutions. “Every day we learn more about
the potential for wearable data to inform personalized healthcare and
through All of Us, the research community will gain an even
better understanding of the role wearable data can play in helping to
prevent and treat disease.”
While Fitbit users can use their device to sync health stats with the
program, a device is not required to participate. All of Us
participants can also choose to connect their data through their Fitbit
account and manually add information such as their weight, water intake
and meals. To get started, participants can log on to the All of Us participant
portal at participant.JoinAllofUs.org
and visit the Sync Apps & Devices page. Fitbit users and others ages 18
and up living in the United States interested in enrolling in the All
of Us Research Program can learn more by visiting www.joinallofus.org.
A second All of Us research initiative using Fitbit devices will
launch in 2019 that involves providing up to 10,000 Fitbit devices to a
diverse set of participants randomly invited to take part. The study,
which will be conducted by Scripps Research Translational Institute,
will generate a unique data set for exploring the relationship between
health indicators such as physical activity, heart rate and sleep in
conjunction with other critical health outcomes that will be captured as
part of All of Us.
Precision Medicine Initiative and All of Us are service marks of the
U.S.
Department of Health & Human Services
.
About Fitbit
Fitbit helps people lead healthier, more active lives by empowering them
with data, inspiration and guidance to reach their goals. As the leading
global wearables brand, Fitbit designs products and experiences that
track and provide motivation for everyday health and fitness. Fitbit’s
diverse line of innovative and popular products include Fitbit Charge
3™, Fitbit Alta HR™, Fitbit Alta®, Fitbit Ace™, Fitbit Flex 2®, and
Fitbit Zip® activity trackers, as well as the Fitbit Ionic™ and Fitbit
Versa™ smartwatches, Fitbit Flyer™ wireless headphones and Fitbit Aria
2™ Wi-Fi Smart Scale. Fitbit products are carried in over 39,000 retail
stores and in 87 countries around the globe. Powered by one of the
world’s largest social fitness networks and databases of health and
fitness data, the Fitbit platform delivers personalized experiences,
insights and guidance through leading software and interactive tools,
including the Fitbit and Fitbit Coach apps, and the Fitbit OS for
smartwatches. Fitbit Health Solutions develops health and wellness
solutions designed to help increase engagement, improve health outcomes,
and drive a positive return for employers, health plans and health
systems.
Fitbit and the Fitbit logo are trademarks or registered trademarks of
Fitbit, Inc. in the U.S. and other countries. Additional Fitbit
trademarks can be found at
www.fitbit.com/legal/trademark-list
.
Third-party trademarks are the property of their respective owners.
Connect with us on Facebook, Instagram or Twitter and share your
Fitbit experience.
Forward-Looking Statements
This press release contains forward-looking statements, within the
meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, that involve risks and uncertainties
including, among other things, statements regarding future research
initiatives using Fitbit devices. These forward-looking statements are
only predictions and may differ materially from actual results due to a
variety of factors, including the effects of the highly competitive
market in which we operate, including competition from much larger
technology companies; any inability to successfully develop and
introduce new products, features, and services or enhance existing
products and services; product liability issues, security breaches or
other defects; and other factors discussed under the heading “Risk
Factors” in our most recent report on Form 10-Q filed with the
Securities and Exchange Commission. All forward-looking statements
contained herein are based on information available to us as of the date
hereof and we do not assume any obligation to update these statements as
a result of new information or future events.
1 Stephen P Wright, Scott R Collier, Tyish S Brown, and
Kathryn Sandberg. An analysis of how consumer physical activity monitors
are used in biomedical research. FASEB Journal. https://www.fasebj.org/doi/abs/10.1096/fasebj.31.1_supplement.1020.24
2 Research Library Update. Fitabase. https://www.fitabase.com/research-library/
3 Andre Henriksen et al. Using Fitness Trackers and
Smartwatches to Measure Physical Activity in Research: Analysis of
Consumer Wrist-Worn Wearables. Journal of Medical Internet Research.
https://www.jmir.org/2018/3/e110/
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190116005260/en/
Fitbit, Inc.
Jen Ralls, 415-941-0037
PR@fitbit.com
Source: Fitbit, Inc.